Document Type



Media is loading

Publication Date



Overall Goals and Objectives:

1. Learn about biomarkers that have utility in sub-setting asthma.

2. Learn how to use biomarkers to select populations for clinical trials of new therapeutics in asthma.

3. Learn how these biomarkers can be used clinically in individual patients.


Dr. Philip Silkoff is currently a Senior Director in Pulmonary Medicine/Immunology at Centocor R&D Inc. (Johnson and Johnson Pharmaceutical Research and Development.) Previously, he was the Medical Director and an Associate Professor at the National Jewish Medical Research Center and University of Colorado Health Sciences Center, Denver, CO. He was awarded Clinician of the Year at the National Jewish Medical and Research Center for many years. His clinical and research interests are the biomarkers of asthma diagnosis and treatment.

Presentation runs 1 hour and 6 minutes.